<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/rapp" ></link>
<id>urn:uuid:cc4b7e67-26c3-2fa0-15f4-81882c7a739e</id>
<updated>2026-09-14T16:25:53-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>RAPP: CEESAY ABRAHAM (CEO,DIR) Sold (AS) 8,210 Shares of RAPPORT THERAPEUTICS INC for $45.55-$46.01 on 9/8</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6466686" ></link>
<id>urn:uuid:c3c95350-cef6-072b-6a82-a15da294ea49</id>
<updated>2026-09-09T16:05:05-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $43.62. Mkt Cap:2.1B. 10D Vol: 305,210]]></summary>
</entry>
<entry>
<title>RAPP: CEESAY ABRAHAM (CEO,DIR) Sold (AS) 18,921 Shares of RAPPORT THERAPEUTICS INC for $49.57 on 8/25</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6460437" ></link>
<id>urn:uuid:9a1b7569-b6bf-f4cb-9505-d55bf38421e2</id>
<updated>2026-08-26T16:05:03-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $43.62. Mkt Cap:2.1B. 10D Vol: 305,210]]></summary>
</entry>
<entry>
<title>RAPP: YELESWARAM KRISHNASWAMY (O) Sold (AS) 50,160 Shares of RAPPORT THERAPEUTICS INC for $50.00-$51.06 on 8/24-8/25</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6460407" ></link>
<id>urn:uuid:133931f2-d0f7-b97c-3f72-c8d8dbec388c</id>
<updated>2026-08-26T16:00:03-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $43.62. Mkt Cap:2.1B. 10D Vol: 305,210]]></summary>
</entry>
<entry>
<title>RAPP: YELESWARAM KRISHNASWAMY (O) Sold (AS) 404 Shares of RAPPORT THERAPEUTICS INC for $49.90 on 8/19</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6457740" ></link>
<id>urn:uuid:84f4b7ab-5cda-813e-3387-e27ad087a799</id>
<updated>2026-08-20T16:09:03-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $43.62. Mkt Cap:2.1B. 10D Vol: 305,210]]></summary>
</entry>
<entry>
<title>RAPP: CEESAY ABRAHAM (CEO,DIR) Sold (AS) 51,499 Shares of RAPPORT THERAPEUTICS INC for $45.97-$48.62 on 8/10-8/11</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6452708" ></link>
<id>urn:uuid:9b3fc4ae-4fe6-2176-fb75-616e58035ef9</id>
<updated>2026-08-12T16:35:43-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $43.62. Mkt Cap:2.1B. 10D Vol: 305,210]]></summary>
</entry>
<entry>
<title>RAPP: CEESAY ABRAHAM (CEO,DIR) Sold (AS) 2,210 Shares of RAPPORT THERAPEUTICS INC for $42.11-$42.73 on 7/27</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6445855" ></link>
<id>urn:uuid:0f079f6e-f4bd-fc34-11d4-580f052b6c99</id>
<updated>2026-07-29T16:05:02-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $43.62. Mkt Cap:2.1B. 10D Vol: 305,210]]></summary>
</entry>
<entry>
<title>RAPP: CEESAY ABRAHAM (CEO,DIR) Sold (AS) 8,210 Shares of RAPPORT THERAPEUTICS INC for $39.72-$40.57 on 7/14</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6441791" ></link>
<id>urn:uuid:1caa1f8d-1292-d283-8259-94c508a684fa</id>
<updated>2026-07-15T16:15:03-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $43.62. Mkt Cap:2.1B. 10D Vol: 305,210]]></summary>
</entry>
<entry>
<title>RAPP: GAULT CHERYL (COO) Sold (AS) 10k Shares of RAPPORT THERAPEUTICS INC for $40.09-$43.15 on 6/30</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6434861" ></link>
<id>urn:uuid:09133399-ea4f-860f-0550-e4ec83a35497</id>
<updated>2026-07-01T16:10:03-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $43.62. Mkt Cap:2.1B. 10D Vol: 305,210]]></summary>
</entry>
<entry>
<title>RAPP: CEESAY ABRAHAM (CEO,DIR) Sold (AS) 8,220 Shares of RAPPORT THERAPEUTICS INC for $39.77-$40.34 on 6/29</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6434834" ></link>
<id>urn:uuid:dd36949f-8200-7dcd-3ec3-8922b78f7d6b</id>
<updated>2026-07-01T16:05:03-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $43.62. Mkt Cap:2.1B. 10D Vol: 305,210]]></summary>
</entry>
<entry>
<title>RAPP: THIRD ROCK VENTURES V L P (BO) Sold (AS) 18,572 Shares of RAPPORT THERAPEUTICS INC for $40.05 on 5/26</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6413884" ></link>
<id>urn:uuid:496403b7-f953-c0f7-0bd3-a7bc39d298d7</id>
<updated>2026-05-28T16:15:04-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $43.62. Mkt Cap:2.1B. 10D Vol: 305,210]]></summary>
</entry>
</feed>